Literature DB >> 8807636

The molecular basis of RU486 resistance in the Tammar Wallaby, Macropus eugenii.

S S Lim-Tio1, M C Keightley, T P Fletcher, P J Fuller.   

Abstract

RU486 acts as a potent anti-progestin in humans but does not antagonise progesterone action in the chicken or hamster reflecting a substitution in the ligand binding domain (LBD) of cysteine for glycine in both the chicken and the hamster progesterone receptor (PR), at the position corresponding to codon 722 of the human PR. The tammar wallaby, Macropus eugenii, is also resistant to the effects of RU486. Cloning of a partial cDNA of the PR in the tammar wallaby reveals a glycine to alanine substitution (gly 722 in the human PR), as well as a glutamine to histidine substitution two amino acids upstream of this alanine residue. Both the glycine and glutamine residues are substituted in all three resistant species. These substitutions are also found in the mineralocorticoid receptor, which also does not bind RU486, and suggest an important role for these residues in the formation of the 11-beta pocket of the receptor, which accommodates the bulky side-chains of 11-beta substituted steroids.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8807636     DOI: 10.1016/0303-7207(96)03807-5

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  3 in total

Review 1.  Helix 3-helix 5 interactions in steroid hormone receptor function.

Authors:  Junhui Zhang; David S Geller
Journal:  J Steroid Biochem Mol Biol       Date:  2008-03-13       Impact factor: 4.292

2.  Regulation by Progestins, Corticosteroids, and RU486 of Transcriptional Activation of Elephant Shark and Human Progesterone Receptors: An Evolutionary Perspective.

Authors:  Xiaozhi Lin; Wataru Takagi; Susumu Hyodo; Shigeho Ijiri; Yoshinao Katsu; Michael E Baker
Journal:  ACS Pharmacol Transl Sci       Date:  2021-12-06

3.  A single glycine-alanine exchange directs ligand specificity of the elephant progestin receptor.

Authors:  Michael Wierer; Anna K Schrey; Ronald Kühne; Susanne E Ulbrich; Heinrich H D Meyer
Journal:  PLoS One       Date:  2012-11-27       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.